Cargando…

2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes

BACKGROUND: Limited evidence suggests that influenza leads not only to bacterial colonization and greater risk of bacterial pneumonia, but to poor outcomes and increased mortality. We compared bacterial culture results between patients positive (FLU+) and negative (FLU-) for influenza in the setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartley, Patricia, Deshpande, Abhishek, Yu, Pei-Chun, Haessler, Sarah, Zilberberg, Marya, Imrey, Peter, Klompas, Michael, Rothberg, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810253/
http://dx.doi.org/10.1093/ofid/ofz360.2470
_version_ 1783462205172219904
author Bartley, Patricia
Deshpande, Abhishek
Yu, Pei-Chun
Haessler, Sarah
Zilberberg, Marya
Imrey, Peter
Klompas, Michael
Rothberg, Michael
author_facet Bartley, Patricia
Deshpande, Abhishek
Yu, Pei-Chun
Haessler, Sarah
Zilberberg, Marya
Imrey, Peter
Klompas, Michael
Rothberg, Michael
author_sort Bartley, Patricia
collection PubMed
description BACKGROUND: Limited evidence suggests that influenza leads not only to bacterial colonization and greater risk of bacterial pneumonia, but to poor outcomes and increased mortality. We compared bacterial culture results between patients positive (FLU+) and negative (FLU-) for influenza in the setting of community-acquired pneumonia (CAP). Among FLU+ patients we compared bacterial etiology, characteristics, treatment and outcomes between patients with and without bacterial coinfection. METHODS: We included adults admitted with pneumonia 2010–2015 to 179 US hospitals participating in the Premier database. Pneumonia was identified using an ICD-9-CM algorithm. Among patients tested for FLU, we limited the microbiology results to the first 14 hospital days. We assessed inpatient mortality, ICU admission, use of vasopressors, mechanical ventilation (MV), cost, and LOS using mixed multiple logistic regression and gamma generalized linear mixed models. RESULTS: Among 166,273 patients hospitalized with CAP, 38,665 (23.3%) were tested for influenza and 4,313 (11.15%) were positive. In FLU+ patients the most common bacterial co-infection was Staphylococcus aureus (37.6%) followed by Streptococcus pneumoniae (25.9%) and Pseudomonas aeruginosa (10.9%), varying based on the day of coinfection (days 1–3 vs. days 4–14) (Figure 1). In FLU- patients, S. pneumoniae (30.5%) and S. aureus (30.3%) were similarly common, followed by P. aeruginosa (10.0%). FLU+ patients with bacterial co-infection were younger (66.3 vs. 69.1 years), with more comorbidities (3.2 vs. 2.7) than influenza patients with no bacterial co-infection (all comparisons P < 0.001). Bacterial co-infection was also associated with increased odds of in-hospital mortality (OR 1.86, 95% CI,1.31–2.65), ICU admission (OR 3.46, 2.44–4.9), use of vasopressors (OR 3.74, 2.61–5.36), and MV (OR 3.51, 2.49–5.36), increased cost (risk-adjusted ratio of geometric means, 1.6, (1.47–1.73) and LOS (risk-adjusted ratio of geometric means 1.42, (1.33–1.52). CONCLUSION: In a large US inpatient sample hospitalized for CAP, 11% of patients with influenza had or acquired a bacterial co-infection. Bacterial co-infection was associated with significantly worse outcomes and higher cost. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810253
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68102532019-10-28 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes Bartley, Patricia Deshpande, Abhishek Yu, Pei-Chun Haessler, Sarah Zilberberg, Marya Imrey, Peter Klompas, Michael Rothberg, Michael Open Forum Infect Dis Abstracts BACKGROUND: Limited evidence suggests that influenza leads not only to bacterial colonization and greater risk of bacterial pneumonia, but to poor outcomes and increased mortality. We compared bacterial culture results between patients positive (FLU+) and negative (FLU-) for influenza in the setting of community-acquired pneumonia (CAP). Among FLU+ patients we compared bacterial etiology, characteristics, treatment and outcomes between patients with and without bacterial coinfection. METHODS: We included adults admitted with pneumonia 2010–2015 to 179 US hospitals participating in the Premier database. Pneumonia was identified using an ICD-9-CM algorithm. Among patients tested for FLU, we limited the microbiology results to the first 14 hospital days. We assessed inpatient mortality, ICU admission, use of vasopressors, mechanical ventilation (MV), cost, and LOS using mixed multiple logistic regression and gamma generalized linear mixed models. RESULTS: Among 166,273 patients hospitalized with CAP, 38,665 (23.3%) were tested for influenza and 4,313 (11.15%) were positive. In FLU+ patients the most common bacterial co-infection was Staphylococcus aureus (37.6%) followed by Streptococcus pneumoniae (25.9%) and Pseudomonas aeruginosa (10.9%), varying based on the day of coinfection (days 1–3 vs. days 4–14) (Figure 1). In FLU- patients, S. pneumoniae (30.5%) and S. aureus (30.3%) were similarly common, followed by P. aeruginosa (10.0%). FLU+ patients with bacterial co-infection were younger (66.3 vs. 69.1 years), with more comorbidities (3.2 vs. 2.7) than influenza patients with no bacterial co-infection (all comparisons P < 0.001). Bacterial co-infection was also associated with increased odds of in-hospital mortality (OR 1.86, 95% CI,1.31–2.65), ICU admission (OR 3.46, 2.44–4.9), use of vasopressors (OR 3.74, 2.61–5.36), and MV (OR 3.51, 2.49–5.36), increased cost (risk-adjusted ratio of geometric means, 1.6, (1.47–1.73) and LOS (risk-adjusted ratio of geometric means 1.42, (1.33–1.52). CONCLUSION: In a large US inpatient sample hospitalized for CAP, 11% of patients with influenza had or acquired a bacterial co-infection. Bacterial co-infection was associated with significantly worse outcomes and higher cost. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810253/ http://dx.doi.org/10.1093/ofid/ofz360.2470 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Bartley, Patricia
Deshpande, Abhishek
Yu, Pei-Chun
Haessler, Sarah
Zilberberg, Marya
Imrey, Peter
Klompas, Michael
Rothberg, Michael
2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
title 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
title_full 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
title_fullStr 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
title_full_unstemmed 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
title_short 2793. Influenza and Bacterial Pneumonia Coinfection: Rates and Outcomes
title_sort 2793. influenza and bacterial pneumonia coinfection: rates and outcomes
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810253/
http://dx.doi.org/10.1093/ofid/ofz360.2470
work_keys_str_mv AT bartleypatricia 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT deshpandeabhishek 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT yupeichun 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT haesslersarah 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT zilberbergmarya 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT imreypeter 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT klompasmichael 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes
AT rothbergmichael 2793influenzaandbacterialpneumoniacoinfectionratesandoutcomes